Latest Innovation News

Genetic Signatures is undertaking a major organisational restructure to cut costs by $5 million and sharpen its commercial focus, aiming to accelerate growth in its diagnostic product offerings.

Algorae Pharmaceuticals has launched a second collaboration with Peter MacCallum Cancer Centre to validate AI-predicted drug combinations across multiple cancer types, aiming to accelerate its drug development pipeline.

Barton Gold Holdings has secured a $520,000 cash refund through the Federal Government’s R&D Tax Incentive, bolstering its exploration efforts in South Australia’s emerging gold province.

SRJ Technologies’ subsidiary ACE has landed two advanced inspection contracts worth a combined £235k with a leading global energy supermajor, reinforcing its foothold in offshore asset integrity services.

Navigator Global Investments has acquired a 4.5% stake in Canadian AI-focused growth equity firm Georgian through a USD 100 million investment, enhancing its exposure to AI-driven private markets.

Sprintex Limited has inked an exclusive distribution agreement with ChoisTechnics Corp. to expand its hydrogen fuel cell compressor presence in South Korea, targeting key mobility and stationary markets.

Ava Risk Group has announced a $7 million strategic investment from US-based Hale Capital to fuel its expansion into the US federal security market and accelerate product development. This partnership aims to position Ava as a global leader in critical infrastructure protection with a strong US presence.

Forrestania Resources has inked a binding agreement with Polaris Engineering to construct a new carbon-in-leach plant at Lake Johnston, aiming for commissioning by November 2026 and a throughput of 3.2 million tonnes per annum.

Fatfish Group has revealed improper conduct by a former service provider that delayed its 2024 financial reporting, while outlining ongoing legal actions and a strategy to relist on the ASX within four months.

4DMedical has achieved CE Mark certification for its groundbreaking CT:VQ™ ventilation-perfusion imaging technology, unlocking the vast European market. The company also raised $83 million to fund rapid expansion across the EU.

1414 Degrees has raised $2.69 million to accelerate its clean energy storage technologies, targeting the booming global data centre market and industrial energy users.

AdAlta’s subsidiary AdCella has completed its first Joint Development Committee meeting with Shanghai Cell Therapy Group, advancing the development of the CAR-T therapy BZDS1901 with potential timeline acceleration and reduced regulatory risks.